SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-098942
Filing Date
2022-04-07
Accepted
2022-04-07 16:36:23
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d287575d424b5.htm 424B5 370886
2 GRAPHIC g287575g0407084812646.jpg GRAPHIC 6625
3 GRAPHIC g287575g0407084812974.jpg GRAPHIC 6347
4 GRAPHIC g287575g05g01.jpg GRAPHIC 51999
  Complete submission text file 0001193125-22-098942.txt   457464
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-253539 | Film No.: 22814328
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences